2019
Inhaled Iloprost Versus Epoprostenol in Heart Transplant Recipients
Enomoto TM, Treggiari MM, Yanez ND, Merkel MJ. Inhaled Iloprost Versus Epoprostenol in Heart Transplant Recipients. Respiratory Care 2019, 64: 743-751. PMID: 30967439, DOI: 10.4187/respcare.06426.Peer-Reviewed Original ResearchConceptsAcute right ventricular dysfunctionHeart transplant recipientsRight ventricular dysfunctionMechanical ventilationEnd pointHeart transplantationHospital stayTransplant recipientsVentricular dysfunctionHemodynamic valuesMedian numberAcute pulmonary hypertensionLength of ICUOrthotopic heart transplantationPrimary end pointSafety end pointSecondary end pointsImmediate postoperative periodPrimary vasodilatorVasoactive medicationsVasodilatory therapyPostoperative bleedingPulmonary hypertensionPostoperative periodConsecutive patients
2006
Risk factors for reperfusion injury after lung transplantation
Cottini SR, Lerch N, de Perrot M, Treggiari MM, Spiliopoulos A, Nicod L, Ricou B. Risk factors for reperfusion injury after lung transplantation. Intensive Care Medicine 2006, 32: 557-563. PMID: 16520995, DOI: 10.1007/s00134-006-0096-7.Peer-Reviewed Original ResearchConceptsReperfusion injuryIntensive care unitPulmonary hypertensionLung transplantationHigher systolic pulmonary pressureSurgical intensive care unitDonor/recipient pairsSystolic pulmonary hypertensionSystolic pulmonary pressureAdministration of catecholaminesDifficult hemostasisSettingRetrospective studyICU mortalityPerioperative hemostasisPostoperative variablesPulmonary pressurePreoperative valuesCare unitMechanical ventilationUniversity HospitalDonor factorsEarly recognitionRisk factorsRecipient pairsRelative odds